Published in Ter Arkh on January 01, 2006
DNA hydrolyzing autoantibodies. Science (1992) 1.88
Cleavage of supercoiled plasmid DNA by autoantibody Fab fragment: application of the flow linear dichroism technique. Proc Natl Acad Sci U S A (1995) 1.08
Detection of DNA domains in Drosophila, human, and plant chromosomes possessing mainly 50- to 150-kilobase stretches of DNA. Proc Natl Acad Sci U S A (1992) 1.08
Forum domain in Drosophila melanogaster cut locus possesses looped domains inside. Nucleic Acids Res (1998) 1.05
Enzyme mimicry by the antiidiotypic antibody approach. Proc Natl Acad Sci U S A (2000) 0.99
Novel functional activities of anti-DNA autoantibodies from sera of patients with lymphoproliferative and autoimmune diseases. Appl Biochem Biotechnol (1998) 0.96
Ovarian function and disease activity in patients with systemic lupus erythematosus. Clin Exp Rheumatol (2008) 0.92
DNA hydrolysis by monoclonal anti-ssDNA autoantibody BV 04-01: origins of catalytic activity. Mol Immunol (1997) 0.90
Autoantibodies to nuclear antigens: correlation between cytotoxicity and DNA-hydrolyzing activity. Appl Biochem Biotechnol (2000) 0.88
[Detection of a new tissue-specific enhancer in the ct6 region of the regulatory region of the drosophila cut locus]. Genetika (1999) 0.87
Blood Clotting Factor VIII: From Evolution to Therapy. Acta Naturae (2013) 0.86
Molecular pathogenesis of systemic lupus erythematosus. Arch Virol (1975) 0.85
Anti-DNA autoantibodies reveal toxicity to tumor cell lines. Immunol Lett (2002) 0.85
[Isolation and characterization of a specific fraction of human chromosome DNA--forum DNA]. Dokl Akad Nauk SSSR (1988) 0.84
Immunoproteasome enhances intracellular proteolysis of myelin basic protein. Dokl Biochem Biophys (2014) 0.84
Sequence specificity of isolated DNA-adenine methylases from Mycobacterium smegmatis (butyricum) and Shigella sonnei 47 cells. Biochem Int (1985) 0.83
[Detection of alternative RNA splicing in the cut locus of D. melanogaster]. Dokl Akad Nauk SSSR (1988) 0.83
DNA-specific antiidiotypic antibodies in the sera of patients with autoimmune diseases. FEBS Lett (1992) 0.83
Endocarditis with left atrial thrombus formation in Behçet's disease mimicking myxoma. J Rheumatol (1993) 0.82
Suppression of ongoing experimental allergic encephalomyelitis in DA rats by novel peptide drug, structural part of human myelin basic protein 46-62. Autoimmunity (2009) 0.81
[Antibodies to various phospholipids in SLE patients with primary antiphospholipid syndrome]. Klin Med (Mosk) (1999) 0.81
[A study of kinetics of endonuclease reactions using flow linear dichroism technique]. Mol Biol (Mosk) (1997) 0.81
Substrate specificity of catalytic autoantibodies in neurodegenerative processes. Dokl Biochem Biophys (2007) 0.80
Sequence specificity of isolated DNA-cytosine methylases from Shigella sonnei 47 cells. Biochem Int (1984) 0.80
[Cardiac rhythm and conduction disorders in polymyositis and dermatomyositis]. Klin Med (Mosk) (1998) 0.80
[Site-specificity of DNA methylases from Shigella sonnei 47 cells]. Biokhimiia (1985) 0.80
[DNA-hydrolyzing antibodies in lymphoproliferative disorders]. Biull Eksp Biol Med (1996) 0.80
DNA-protein complexes. Natural targets for DNA-hydrolyzing antibodies. Appl Biochem Biotechnol (1994) 0.80
[Effect of exogenous interferon and various interferon inducers on the indicators of general reactivity in systemic lupus erythematosus]. Ter Arkh (1980) 0.79
Coagulation Factor IX for Hemophilia B Therapy. Acta Naturae (2012) 0.79
DNA hydrolysis by monoclonal autoantibody BV 04-01. Appl Biochem Biotechnol (2000) 0.79
[A novel approach to the study of topoisomerase I kinetics]. Dokl Akad Nauk (1998) 0.78
[Catalytic autoantibodies--a new molecular instrument in cardiology and ophthalmology]. Ter Arkh (2006) 0.78
Recombinant human butyrylcholinesterase as a new-age bioscavenger drug: development of the expression system. Acta Naturae (2013) 0.78
[The HLA-B5 immunogenetic marker in Behçet's disease]. Ter Arkh (1993) 0.78
Creation of catalytic antibodies metabolizing organophosphate compounds. Biochemistry (Mosc) (2012) 0.78
Role of Structure-Based Changes due to Somatic Mutation in Highly Homologous DNA-Binding and DNA-Hydrolyzing Autoantibodies Exemplified by A23P Substitution in the VH Domain. Autoimmune Dis (2012) 0.78
[Characteristics of retinal vascular involvement in systemic lupus erythematosus]. Vestn Oftalmol (2001) 0.78
[Clinical significance of determining antibodies to poly A: poly U in systemic lupus erythematosus]. Ter Arkh (1972) 0.78
[Atherogenic cholesterol-containing circulating immune complexes--one of the components of the serum in patients with systemic lupus erythematosus]. Klin Med (Mosk) (2003) 0.78
Stable Expression of Recombinant Factor VIII in CHO Cells Using Methotrexate-Driven Transgene Amplification. Acta Naturae (2012) 0.77
[Behçet's disease: clinical and demographic associations]. Ter Arkh (2013) 0.77
Antibodies-antidotes against organophosphorus compounds. Dokl Biochem Biophys (2009) 0.77
[Dna-specific catalytic antibodies in human blood sera]. Dokl Akad Nauk SSSR (1991) 0.77
[Expression of human serum albumin in metylotrophic yeast Pichia pastoris and its structural and functional analysis]. Bioorg Khim (2008) 0.77
DNA-hydrolyzing Ab: is catalytic activity a clue for physiological significance? Autoimmunity (2009) 0.77
[Role of antiphospholipid antibodies in occlusion of retinal vessels in various vascular eye diseases]. Vestn Oftalmol (2002) 0.77
In vivo DNA damage and resistance to 1-methyl-1-nitrosourea and 1,3-bis(2-chloroethyl)-1-nitrosourea in L1210 leukemia cells. Neoplasma (1988) 0.77
[Immunogenetic HLA markers of chronic viral hepatitis]. Ter Arkh (2005) 0.77
[Cardiological aspects of the antiphospholipid syndrome. Part I. Valvular lesions in the primary and secondary antiphospholipid syndrome and systemic lupus erythematosus]. Kardiologiia (2002) 0.77
[Antibodies to beta2-glycoprotein I in systemic lupus erythematosus: new laboratory marker of antiphospholipid syndrome]. Klin Med (Mosk) (1998) 0.76
[Therapeutic effect of encapsulated into the nanocontainers MBP immunodominant peptides on EAE development in DA rats]. Bioorg Khim (2012) 0.76
Natural antibody catalytic activities in mice with autoimmune disorders. Dokl Biochem (2001) 0.76
[The role of estrogen-androgen imbalance in rheumatic diseases]. Ter Arkh (1990) 0.76
[Isolation and characteristics of catalytic antibodies to DNA in systemic lupus erythematosis]. Biokhimiia (1993) 0.76
β1 integrin as the integrating component in cell-cell cooperation for maintenance of lens transparency. Dokl Biochem Biophys (2014) 0.76
Site-specific degradation of myelin basic protein by the proteasome. Dokl Biochem Biophys (2009) 0.76
[Cytokines and their role in pathogenesis of diabetic retinopathy]. Vestn Oftalmol (2011) 0.76
Substrate specificity of the anthrax lethal factor. Dokl Biochem Biophys (2008) 0.76
[Diagnostic and pathogenetic implications of the site specificity of antibody proteases in multiple sclerosis]. Vestn Ross Akad Med Nauk (2010) 0.76
[The current concept of immunological disorders in the case of basal-cell carcinoma]. Arkh Patol (2009) 0.76
[Structural-functional study of recombinant forms of onconase]. Bioorg Khim (2001) 0.76
[Aproaches to immunotherapy in different immunophenotypes of cutaneous basal cell carcinoma]. Vopr Onkol (2012) 0.76
[DNA-abzymes in rheumatoid arthritis: pathogenetic and clinical significance]. Ter Arkh (2005) 0.76
Endothelial inclusions and "nuclear bodies" in systemic lupus erythematosus. Ann Rheum Dis (1973) 0.75
[Functional degradation of myelin basic protein. Proteomic approach]. Bioorg Khim (2011) 0.75